SEC Filings for T2 Biosystems Inc. (TTOO)

$ 1.55   -0.07 (-4.32%) Volume: 5.52m 4:00 PM EDT 4-Aug-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)407/14/2020
8-KCurrent report pursuant to Section 13 or 15(d)906/30/2020
DEFA14AAdditional proxy soliciting materials - definitive506/26/2020
DEF 14AOther definitive proxy statements6706/26/2020
3Initial statement of beneficial ownership of securities206/22/2020
3Initial statement of beneficial ownership of securities206/22/2020
3Initial statement of beneficial ownership of securities206/22/2020
8-KCurrent report pursuant to Section 13 or 15(d)306/17/2020
8-KCurrent report pursuant to Section 13 or 15(d)306/15/2020
PRE 14APreliminary proxy statement providing notification matters to be brought to a vote6506/15/2020
SDSpecialized Disclosure Report905/29/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans1305/27/2020
8-KCurrent report pursuant to Section 13 or 15(d)305/22/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)5305/11/2020
8-KCurrent report pursuant to Section 13 or 15(d)1605/08/2020
<<
First
<
Prev
123456789101112131415